全文获取类型
收费全文 | 5951篇 |
免费 | 315篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 109篇 |
妇产科学 | 165篇 |
基础医学 | 1032篇 |
口腔科学 | 169篇 |
临床医学 | 441篇 |
内科学 | 968篇 |
皮肤病学 | 119篇 |
神经病学 | 621篇 |
特种医学 | 219篇 |
外国民族医学 | 1篇 |
外科学 | 629篇 |
综合类 | 22篇 |
预防医学 | 777篇 |
眼科学 | 125篇 |
药学 | 438篇 |
中国医学 | 15篇 |
肿瘤学 | 418篇 |
出版年
2022年 | 52篇 |
2021年 | 100篇 |
2020年 | 66篇 |
2019年 | 84篇 |
2018年 | 108篇 |
2017年 | 95篇 |
2016年 | 91篇 |
2015年 | 106篇 |
2014年 | 169篇 |
2013年 | 188篇 |
2012年 | 319篇 |
2011年 | 352篇 |
2010年 | 191篇 |
2009年 | 160篇 |
2008年 | 288篇 |
2007年 | 313篇 |
2006年 | 256篇 |
2005年 | 328篇 |
2004年 | 306篇 |
2003年 | 252篇 |
2002年 | 278篇 |
2001年 | 196篇 |
2000年 | 204篇 |
1999年 | 165篇 |
1998年 | 75篇 |
1997年 | 60篇 |
1996年 | 50篇 |
1995年 | 59篇 |
1994年 | 33篇 |
1992年 | 78篇 |
1991年 | 73篇 |
1990年 | 100篇 |
1989年 | 86篇 |
1988年 | 67篇 |
1987年 | 64篇 |
1986年 | 71篇 |
1985年 | 74篇 |
1984年 | 53篇 |
1983年 | 57篇 |
1980年 | 29篇 |
1979年 | 66篇 |
1978年 | 34篇 |
1977年 | 32篇 |
1975年 | 29篇 |
1974年 | 39篇 |
1973年 | 31篇 |
1972年 | 33篇 |
1971年 | 33篇 |
1969年 | 39篇 |
1968年 | 29篇 |
排序方式: 共有6315条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
995.
Pain is defined by the International Association for Study of Pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage." This article reviews the medical management of chronic pain. 相似文献
996.
László Marsovszky Miklós D. Resch Zsuzsanna Visontai János Németh 《Pathology oncology research : POR》2014,20(3):741-746
The recently developed confocal cornea microscopy offers the opportunity to examine pathologies of the cornea and to gain insight into the activity of innate immunity. We aimed to investigate the corneal epithelial and Langerhans cell (LC) densities along with dry eye parameters in primary open-angle glaucoma (POAG) subjects, treated with either of two commercially available travoprost 0.004 % topical medications containing different preservatives. (1: benzalkonium chloride 0.015 % (TravBAK) and 2: polyquaternium-1 (PQ) 0.001 % (TravPQ). Consecutive case series of nineteen POAG patients on TravBAK (mean age: 64.8?±?13.6 years), nineteen POAG patients on TravPQ (mean age: 66.8?±?11.3 years) and nineteen age-matched healthy control subjects (63.8?±?8.2 years). Ocular surface disease index (OSDI), lid parallel conjunctival folds (LIPCOF), Schirmer test (ST) and tear break up time (TBUT) were assessed, and then corneal epithelial and LC densities were investigated with confocal microscopy. Tear production was significantly reduced in both glaucoma patient groups compared to healthy individuals (p?<?0.05). TBUT was significantly reduced and epithelial cell densities were significantly greater in patients treated with TravBAK compared to healthy individuals (p?<?0.05 for all). LC densities were greater in both glaucoma groups compared to control subjects (p?<?0.05 for all). Travoprost therapy may compromise ocular surface. The limited alertness of the corneal immune system found in patients with TravPQ can be considered as indicators of a less disturbed ocular surface and better controlled corneal homeostasis. 相似文献
997.
Eszter Sári Zsolt György Nagy Kornélia Baghy Hajnalka Rajnai Csaba Bödör Judit Csomor Gábor Barna Gábor Rudas Ilona Kovalszky Judit Demeter 《Pathology oncology research : POR》2014,20(4):973-980
Hairy cell leukemia is a rare chronic lymphoproliferative disorder with indolent but progressive clinical course. Patients require treatment when they have significant cytopenia or recurrent infections. The gold standard treatment are purine nucleoside analogues (cladribine and pentostatine), with these agents the rate of complete remission can approach even 95 %. The differential diagnosis between classical hairy cell leukemia and other, rare splenic lymphomas that can mimic this disease might be really challenging. Splenic lymphoma with villous lymphocytes and other new, provisional WHO entities share some, but not all immunophenotypical features with hairy cell leukemia. The correct diagnosis is of an extreme importance as these entities require different treatment. Thus further investigation in the pathogenesis of hairy cell leukemia is required in order to solve this challenge. Discovery of the BRAF V600E mutation as a disease-defining genetic event in hairy cell leukemia can be helpful in both differential diagnosis and treatment of this disease. We report the case of three hairy cell leukemia patients, whose diagnosis or treatment was based on this newly discovered somatic mutation, but the treatment results and side effects were individual. 相似文献
998.
Gemma Gatta Laura Botta Silvia Rossi Tiiu Aareleid Magdalena Bielska-Lasota Jacqueline Clavel Nadya Dimitrova Zsuzsanna Jakab Peter Kaatsch Brigitte Lacour Sandra Mallone Rafael Marcos-Gragera Pamela Minicozzi Maria-José Sánchez-Pérez Milena Sant Mariano Santaquilani Charles Stiller Andrea Tavilla Rafael Peris-Bonet 《The lancet oncology》2014,15(1):35-47
999.
Peter D. Westenskow Toshihide Kurihara Edith Aguilar Elizabeth L. Scheppke Stacey K. Moreno Carli Wittgrove Valentina Marchetti Iacovos P. Michael Sudarshan Anand Andras Nagy David Cheresh Martin Friedlander 《The Journal of clinical investigation》2013,123(11):4900-4908
Vascular networks develop from a growing vascular front that responds to VEGF and other guidance cues. Angiogenesis is required for normal tissue function, but, under conditions of stress, inappropriate vascularization can lead to disease. Therefore, inhibition of angiogenic sprouting may prevent neovascularization in patients with blinding neovascular eye diseases, including macular degeneration. VEGF antagonists have therapeutic benefits but also can elicit off-target effects. Here, we found that the Ras pathway, which functions downstream of a wide range of cytokines including VEGF, is active in the growing vascular front of developing and pathological vascular networks. The endogenous Ras inhibitor p120RasGAP was expressed predominately in quiescent VEGF-insensitive endothelial cells and was ectopically downregulated in multiple neovascular models. MicroRNA-132 negatively regulated p120RasGAP expression. Experimental delivery of α-miR-132 to developing mouse eyes disrupted tip cell Ras activity and prevented angiogenic sprouting. This strategy prevented ocular neovascularization in multiple rodent models even more potently than the VEGF antagonist, VEGF-trap. Targeting microRNA-132 as a therapeutic strategy may prove useful for treating multiple neovascular diseases of the eye and for preventing vision loss regardless of the neovascular stimulus. 相似文献
1000.
Major congenital malformations, including those affecting the cardiovascular system, remain the leading cause of mortality and morbidity in infants of diabetic mothers. Interestingly, targeted mutations of several genes (including VEGF and VEGF receptors) and many teratogenic agents (including excess D-glucose) that give rise to embryonic lethal phenotypes during organogenesis are associated with a failure in the formation and/or maintenance of a functional vitelline circulation. Given the similarities in the pathology of the abnormal vitelline circulation in many of these conditions, we hypothesized that the hyperglycemic insult present in diabetes could cause the resultant abnormalities in the vitelline circulation by affecting VEGF/VEGF receptor signaling pathway(s). In this study we report that hyperglycemic insult results in reduced levels of VEGF-A in the conceptus, which in turn, leads to abnormal VEGF receptor signaling, ultimately resulting in embryonic (vitelline) vasculopathy. These findings and our observation that addition of exogenous rVEGF-A(165) within a defined concentration range blunts the hyperglycemia-induced vasculopathy in the conceptus support the concept that VEGF levels can be modulated by glucose levels. In addition, these findings may ultimately lead to novel therapeutic approaches for the treatment of selected congenital cardiovascular abnormalities associated with diabetes. 相似文献